X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-06-12 | FGEN | Adib Deyaa | Chief Medical Officer | P - Purchase | $1.17 | +22,123 | 82,123 | +37% | +$25,884 | ||||||
2024-03-07 | FGEN | Wettig Thane | CEO | P - Purchase | $1.91 | +50,000 | 471,178 | +12% | +$95,470 | ||||||
2023-09-01 | FGEN | Henderson Jeffrey William | Dir | S - Sale | $1.03 | -2,000 | 28,866 | -6% | -$2,060 | ||||||
2023-08-04 | FGEN | Henderson Jeffrey William | Dir | S - Sale | $1.91 | -2,000 | 30,866 | -6% | -$3,820 | ||||||
2023-07-11 | FGEN | Henderson Jeffrey William | Dir | S - Sale | $2.69 | -2,000 | 32,866 | -6% | -$5,380 | ||||||
2023-07-07 | FGEN | Conterno Enrique A | CEO | S - Sale | $2.80 | -1,880 | 402,522 | 0% | -$5,264 | ||||||
2023-06-23 | FGEN | Wettig Thane | Chief Commercial Officer | S - Sale | $16.53 | -791 | 108,261 | -1% | -$13,075 | ||||||
| A | 2023-06-07 | FGEN | Wettig Thane | Chief Commercial Officer | S - Sale | $17.04 | -1,758 | 109,052 | -2% | -$29,951 | |||||
| M | 2023-06-13 | FGEN | Chung Christine | SVP, China Operations | S - Sale | $17.19 | -12,500 | 236,327 | -5% | -$214,925 | |||||
| D | 2023-06-09 | FGEN | Cravatt Benjamin | Dir | S - Sale+OE | $17.17 | -3,944 | 28,736 | -12% | -$67,717 | |||||
| D | 2023-06-09 | FGEN | Brennan Aoife | Dir | S - Sale+OE | $17.19 | -4,733 | 27,947 | -14% | -$81,367 | |||||
| D | 2023-06-09 | FGEN | Blaug Suzanne | Dir | S - Sale+OE | $17.20 | -8,520 | 29,594 | -22% | -$146,571 | |||||
| D | 2023-06-08 | FGEN | Ho Maykin | Dir | S - Sale+OE | $17.44 | -8,520 | 31,501 | -21% | -$148,591 | |||||
| D | 2023-06-09 | FGEN | Edwards Jeffrey L | Dir | S - Sale+OE | $17.19 | -7,889 | 33,977 | -19% | -$135,622 | |||||
| D | 2023-06-08 | FGEN | Henderson Jeffrey William | Dir | S - Sale+OE | $17.46 | -7,000 | 34,866 | -17% | -$122,185 | |||||
| D | 2023-06-07 | FGEN | Schoeneck James A | Dir | S - Sale+OE | $18.03 | -7,100 | 102,488 | -6% | -$127,987 | |||||
2023-06-07 | FGEN | Wettig Thane | Chief Commercial Officer | S - Sale | $17.04 | -1,758 | 111,395 | -2% | -$29,951 | ||||||
2023-06-07 | FGEN | Graham Juan | CFO | S - Sale | $16.99 | -1,785 | 71,083 | -2% | -$30,320 | ||||||
2023-06-07 | FGEN | Chung Christine | SVP, China Operations | S - Sale | $17.04 | -3,633 | 248,827 | -1% | -$61,894 | ||||||
2023-06-07 | FGEN | Eisner Mark | EVP, Chief Medical Officer | S - Sale | $17.04 | -2,042 | 162,862 | -1% | -$34,792 | ||||||
2023-06-07 | FGEN | Conterno Enrique A | CEO | S - Sale | $17.04 | -8,897 | 404,402 | -2% | -$151,583 | ||||||
2023-06-02 | FGEN | Eisner Mark | EVP, Chief Medical Officer | S - Sale | $18.83 | -1,090 | 164,904 | -1% | -$20,525 | ||||||
2023-04-10 | FGEN | Conterno Enrique A | CEO | S - Sale | $19.52 | -1,869 | 410,799 | 0% | -$36,483 | ||||||
2023-04-04 | FGEN | Eisner Mark | Chief Medical Officer | S - Sale | $18.78 | -9,182 | 165,994 | -5% | -$172,473 | ||||||
2023-04-04 | FGEN | Chung Christine | SVP, China Operations | S - Sale | $18.78 | -6,590 | 252,460 | -3% | -$123,785 | ||||||
2023-03-23 | FGEN | Wettig Thane | Chief Commercial Officer | S - Sale | $18.71 | -905 | 110,653 | -1% | -$16,933 | ||||||
| A | 2023-03-10 | FGEN | Conterno Enrique A | CEO | S - Sale | $20.20 | -19,489 | 384,868 | -5% | -$393,625 | |||||
| M | 2023-03-08 | FGEN | Chung Christine | SVP, China Operations | S - Sale | $20.70 | -15,960 | 259,050 | -6% | -$330,357 | |||||
| M | 2023-03-08 | FGEN | Conterno Enrique A | CEO | S - Sale | $20.62 | -56,261 | 412,668 | -12% | -$1,159,971 | |||||
| M | 2023-03-08 | FGEN | Eisner Mark | Chief Medical Officer | S - Sale | $20.60 | -17,503 | 175,176 | -9% | -$360,572 | |||||
| M | 2023-03-08 | FGEN | Graham Juan | CFO | S - Sale | $20.54 | -7,661 | 72,868 | -10% | -$157,367 | |||||
| M | 2023-03-08 | FGEN | Wettig Thane | Chief Commercial Officer | S - Sale | $20.63 | -13,934 | 111,558 | -11% | -$287,435 | |||||
2023-03-02 | FGEN | Eisner Mark | Chief Medical Officer | S - Sale | $21.87 | -1,187 | 172,496 | -1% | -$25,960 | ||||||
2023-01-06 | FGEN | Conterno Enrique A | CEO | S - Sale | $19.95 | -1,538 | 323,283 | 0% | -$30,683 | ||||||
| A | 2022-12-08 | FGEN | Chung Christine | SVP, China Operations | S - Sale | $15.79 | -2,595 | 234,873 | -1% | -$40,975 | |||||
2022-12-23 | FGEN | Wettig Thane | Chief Commercial Officer | S - Sale | $15.80 | -734 | 89,163 | -1% | -$11,597 | ||||||
| AM | 2022-12-09 | FGEN | Graham Juan | CFO | S - Sale | $14.64 | -2,188 | 47,962 | -4% | -$32,031 | |||||
2022-12-08 | FGEN | Graham Juan | CFO | S - Sale | $14.89 | -5,741 | 50,150 | -10% | -$85,498 | ||||||
| M | 2022-12-09 | FGEN | Graham Juan | CFO | S - Sale | $14.64 | -2,188 | 53,703 | -4% | -$32,038 | |||||
2022-12-08 | FGEN | Chung Christine | SVP, China Operations | S - Sale | $15.79 | -1,096 | 237,705 | 0% | -$17,306 | ||||||
2022-12-08 | FGEN | Wettig Thane | Chief Commercial Officer | S - Sale | $15.79 | -382 | 89,897 | 0% | -$6,032 | ||||||
2022-12-08 | FGEN | Conterno Enrique A | CEO | S - Sale | $15.79 | -2,543 | 324,820 | -1% | -$40,154 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |